Attenuated Salmonella typhimurium reduces ovalbumin-induced airway inflammation and T-helper type 2 responses in mice

Clinical and Experimental Immunology

Volumn 145, Issue 1, 2006, Pages 116-122

  Wu, C J ^a   Chen, L C ^b   Kuo, M L ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b Department of Paediatrics   (Taiwan)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Airway inflammation; Asthma; Cytokines; Salmonella; Th2 cells; Vaccine

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; LIVE VACCINE; OVALBUMIN; SALMONELLOSIS VACCINE; SL 7207;

ALLERGIC DISEASE; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HISTOLOGY; IMMUNOPATHOLOGY; LUNG; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SALMONELLA TYPHIMURIUM; SPLEEN CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OVALBUMIN; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; SPLEEN; TH2 CELLS; VACCINES, ATTENUATED;

EID: 33745129696     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03099.x     Document Type: Article

References (44)

1. Beasley R Crane J Lai CK Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000 105 : 466 72.
2. Arm JP Lee TH. The pathobiology of bronchial asthma. Adv Immunol 1992 51 : 323 82.
3. Busse WW Lemanske RF Jr. Asthma. N Engl J Med 2001 344 : 350 62.
4. Umetsu DT Mclntire JJ Akbari O Macaubas C DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002 3 : 715 20.
5. Sutton BJ Gould HJ. The human IgE network. Nature 1993 366 : 421 8.
6. Haas H Falcone FH Holland MJ Schramm G Haisch K Gibbs BF Bufe A Schlaak M. Early interleukin-4. its role in the switch towards a Th2 response and IgE-mediated allergy. Int Arch Allergy Immunol 1999 119 : 86 94.
7. Kay AB Barata L Meng O Durham SR Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997 113 : 196 9.
8. Simon HU Yousefi S Schranz C Schapowal A Bachert C Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997 158 : 3902 8.
9. Herz U Gerhold K Gruber C Braun A Wahn U Renz H Paul K. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998 102 : 867 74.
10. Tulic MK Wale JL Holt PG Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000 22 : 604 12.
11. Hopfenspirger MT Agrawal DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002 268 : 2516 22.
12. Rodriguez D Keller AC Faquim-Mauro EL de Macedo MS Cunha FQ Lefort J Vargaftig BB Russo M. Bacterial lipopolysaccharide signaling through toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003 171 : 1001 8.
13. Shirakawa T Enomoto T Shimazu S Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997 275 : 77 9.
14. Wills-Karp M Santeliz J Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001 1 : 69 75.
15. Erb KJ Holloway JW Sobeck A Moll H Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998 187 : 561 9.
16. Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol 2002 14 : 644 51.
17. VanCott JL Chatfield SN Roberts M Hone DM. Regulation of host immune responses by modification of salmonella virulence genes. Nat Med 1998 4 : 1247 52.
18. Hassan JO. Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-type Salmonella strains. Infect Immunity 1996 64 : 938 44.
19. Fox BC. Safety and efficacy of an avirulent live Salmonella choleraesuis vaccine for protection of calves against S. dublin infection. Am J Vet Res 1997 58 : 265 71.
20. Garmory HS Brown KA Titball RW. Salmonella vaccines for use in human: present and future perspectives. FEMS Microbiol Rev 2002 26 : 339 53.
21. Darji A Guzman CA Gerstel B Wachholz P Timmis KN Wehland J Chakraborty T Weiss S. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997 91 : 765 75.
22. Urashima M Suzuki H Yuza Y Akiyama M Ohno N Eto Y. An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium. Blood 2000 95 : 1258 63.
23. Li Y Guo K Chen H Xie Y Song C Tang X Ren D. Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium. Int J Cancer 2001 94 : 438 43.
24. Stocker BAD. Aromatic-dependent Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J Biotech 2000 83 : 45 50.
25. Flo J Tisminetzky S Baralle F. Oral transgene vaccination mediated by attenuated Salmonella is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine 2001 19 : 1772 82.
26. Chen LC Zhang Z Myers AC Huang SK. Altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10 kDa protein. J Immunol 2001 167 : 3025 8.
27. Harrison JA Villarreal-Ramos B Mastroeni P Demarco de Hormaeche R. Hormaeche CE. Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model. Immunol 1997 90 : 618 25.
28. Jones BD. Salmonellosis: host immune responses and bacterial virulence determinants. Annu Rev Immunol 1996 14 : 533 61.
29. Thatte J Rath S Bal V. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-γ-dominant versus an IL-4-dominant immune response. Int Immunol 1993 5 : 1431 6.
30. Soo S-S Villarreal-Ramos B Khan CMA. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset response and protection against Leishmanial challenge. Inf Immunity 1998 66 : 1910 7.
31. Santos AB Chapman MD Aalberse RC et al. Cockroach allergens and asthma in Brazil. Identification of tropomyosin as a major allergen with potential cross- reactivity with mite and shrimp allergens. J Allergy Clin Immunol 1999 104 : 329 37.
32. Leung TF Lam CW Chan IH Li AM Ha G Tang NL Fok TF. Inhalant allergens as risk factors for the development and severity of mild-to-moderate asthma in Hong Kong Chinese children. J Asthma 2002 39 : 323 30.
33. Smith JJ Van Loverent H Hoekstra MO Schijf MA Folkerts G Nijkamp FP. Mycobacterium vaccine administration during allergen sensitization or challenge suppresses asthmatic features. Clin Exp Allergy 2003 33 : 1083 9.
34. Neutra MR Pringault E Kraehenbuhl J-P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996 14 : 275 300.
35. Siebers A Finlay BB. M cells and pathogenesis of mucosal and system infection. Trends Microbiol 1996 4 : 22 9.
36. O'Neill LAJ Fitzgerald KA Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003 24 : 286 9.
37. Tapping RI Akashi S Miyake K Godowski PJ Tobias PS. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2000 165 : 5780 7.
38. Modzhitov R Preston-Hurlburt P Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997 388 : 394 7.
39. Weinmann AS Mitchell DM Sanjabi MN Bradley MN Hoffmann A Liou HC Smale ST. Nucleosome remodeling at the IL-12 p40 promotor is a TLR-dependent, rel-independent event. Nat Immunol 2001 2 : 51 7.
40. Bonfield TL Konstan MW Burfeind P Panuska JR Hilliard JB Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995 13 : 257 61.
41. Makela MJ Kanehiro A Borish L et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci USA 2000 97 : 6007 12.
42. Mocellin S Panelli MC Wang E Nagorsen D Marincola FM. The dual role of IL-10. Trends Immunol 2003 24 : 36 43.
43. Ho IC Glimcher LH. Transcription: tantalizing times for T cells. Cell 2002 109 : S109 20.
44. Encinas JA Janssen EM Weiner DB Calarota SA Nieto D Moll T Carlo DJ Moss RB. Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases Th2 airway inflammation in a mouse model of asthma. J Allergy Clin Immunol 2005 116 : 1343 9.